Drug information for CUTIVATE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CREAM; TOPICAL 0.05% Prescription AB (Reference Drug) FLUTICASONE PROPIONATE fluticasone FOUGERA PHARMS 19958
2010-09-08 Letter
2010-09-07 Label
2002-04-16 Letter
2002-04-16 Label
1999-06-17 Letter
1999-06-17 Review
1999-06-17 Label
1999-06-17 Letter
1999-06-17 Label
LOTION; TOPICAL 0.05% Prescription AB (Reference Drug) FLUTICASONE PROPIONATE fluticasone FOUGERA PHARMS 21152
2011-05-16 Letter
2011-05-16 Label
2010-09-08 Letter
2010-09-07 Label
2007-09-10 Review
2005-04-06 Letter
OINTMENT; TOPICAL 0.005% Prescription AB (Reference Drug) FLUTICASONE PROPIONATE fluticasone FOUGERA PHARMS 19957
2004-06-02 Label
2003-06-10 Label
2003-06-10 Label
2003-04-08 Letter

Drug Adverse Effects information for CUTIVATE

Role code Indications Reaction # Reports
C ASTHMA ECZEMA 1
C ASTHMA ERYTHEMA 1
C ASTHMA HYPERSENSITIVITY 1
C ASTHMA PRURITUS 1
C ASTHMA RASH 1
C ASTHMA SKIN HAEMORRHAGE 1
C ASTHMA SKIN WARM 1
C ASTHMA STAPHYLOCOCCAL INFECTION 1
C COUGH CONVULSION 1
C COUGH DEATH 1
C DIARRHOEA CONVULSION 1
C DIARRHOEA DEATH 1
C HEADACHE CONVULSION 1
C HEADACHE DEATH 1
C HEPATIC NEOPLASM MALIGNANT CONVULSION 1
C HEPATIC NEOPLASM MALIGNANT DEATH 1
C HEPATITIS B CONVULSION 1
C HEPATITIS B DEATH 1
C RASH CONVULSION 3
C RASH DEATH 3
Ads by Google